Parameter | Condition | Median survival (months) | Hazard ratio | Univariate | Multivariate | |
---|---|---|---|---|---|---|
With condition | Without condition | (95% CI) | p | p | ||
All patients (n = 191) | -26- | - | ||||
Gender | Male | 30 | 25 | 0.953 (0.641–1.417) | 0.812 | NI |
Age (years)1 | > 67 | 26 | 27 | 1.050 (0.706–1.561) | 0.811 | NI |
Distant metastasis | Yes | 11 | 27 | 2.044 (0.892–4.688) | 0.091 | NI |
Neoadjuvant tx | Yes | 25 | 26 | 1.536 (0.741–3.182) | 0.248 | NI |
PVR | Yes | 25 | 27 | 1.640 (1.068–2.517) | 0.024 | 0.510 |
Tumor size (mm)1 | > 25 | 26 | 26 | 1.069 (0.699–1.635) | 0.759 | NI |
Tumor grade | G3/4 | 17 | 31 | 1.808 (1.199–2.726) | 0.005 | 0.075 |
pT stage | pT3/4 | 23 | 41 | 1.938 (1.160–3.238) | 0.012 | 0.905 |
pN stage | pN1/2 | 22 | 52 | 1.883 (1.198–2.959) | 0.006 | 0.211 |
LNR1 | > 0.09 | 20 | 48 | 2.291 (1.515–3.465) | 0.000 | 0.019 |
Lymphangiosis | Present | 22 | 30 | 1.557 (1.035–2.342) | 0.033 | 0.398 |
Hemangiosis | Present | 12 | 29 | 1.900 (1.161–3.109) | 0.011 | 0.384 |
Perineural invasion | Present | 25 | 29 | 1.322 (0.881–1.984) | 0.177 | NI |
Precursor lesion | Present | NR | 25 | 0.362 (0.175–0.748) | 0.006 | 0.169 |
Resection margins | Positive | 19 | 37 | 2.368 (1.551–3.617) | 0.000 | 0.132 |
Tumor subtype2 | See Table 4 | 1.487 (1.253–1.765) | 0.000 | 0.006 | ||
Tumor location2 | See Table 4 | 1.471 (1.175–1.843) | 0.001 | 0.270 | ||
CK7 + (%)1 | > 90 | 20 | 38 | 1.757 (1.161–2.657) | 0.008 | 0.869 |
CK20 + (%)1 | > 0 | 29 | 23 | 0.311 (0.538–1.218) | 0.311 | NI |
CDX2 + (%)1 | > 10 | 48 | 20 | 0.562 (0.368–0.858) | 0.008 | 0.767 |